When discussing vaccinations, you quickly end up with the individual case: this side effect, that study, this expert. What’s rarely asked is the foundation: was the central assumption — vaccination protects — ever empirically established?
This isn’t a question from a Telegram channel. It’s a methodological question found in peer-reviewed journals, raised by physicians who have been vaccinating for decades.
Three Countries, Three Answers, One Question #
How long does a tetanus vaccination protect?
- Germany: Booster every 10 years
- Switzerland: Single booster in early adulthood — then lifelong
- Travel Medicine Zürich: “Every 10 years”
- WHO: Country-specific, no uniform recommendation
Three official sources from the same region. Three different answers.
If the duration of protection were empirically well-established — a single, reproducible answer existed — every country would have the same recommendation. The opposite is the case.
Switzerland changed its recommendation. That means: millions of people who received a booster every 10 years for decades were possibly unnecessarily exposed to an injection. Or: the previous recommendation was not evidence-based. Neither is a reassuring conclusion.
What Would Actually Need to Be Proven #
For a reliable statement “vaccine X protects for Y years,” you would need:
- A randomized controlled trial with genuine placebo (saline solution) as the control group
- Long-term follow-up beyond the claimed protection period
- Independent replication by different research groups
- Clear distinction between antibody titers (laboratory values) and actual clinical protection
None of these points is fully met for most standard vaccinations. That’s not a claim — it’s the current state of research, documented in the specialist literature.
Why Does This Matter? #
Because all downstream questions — side effect profile, mandates, liability, long-term effects — build on this foundation. If the foundation is shaky, everything hangs from it.
In the following parts of this series, we examine the individual aspects:
- The placebo problem: when the control group is contaminated
- Historical precedents: SV40, the Cutter Incident, Swine Flu 1976
- The liability question: why do you need protection if it’s safe?
- mRNA — the current state
- What would be needed to prove it?
Sources:
- Swiss Society of Gynaecology and Obstetrics (SGGG): Optimization of booster vaccinations — sggg.ch
- Travel Medicine UZH, Tetanus: reisemedizin.uzh.ch
- Swiss Federal Office of Public Health (BAG), Tetanus: bag.admin.ch
